ACKNOWLEDGMENTS This pamphlet was produced through a collaboration between the AIM at Melanoma Foundation and Terranova Medica, LLC. We wish to thank our consultant faculty for directing and reviewing the content: Anna Pavlick, BSN, MSc, DO, MBA Professor of Medicine, Division of Hematology & Medical Oncology Weill Cornell Medicine College New York, New York
Michael A. Postow, MD Co-Lead, Melanoma Disease Management Team Memorial Sloan Kettering Cancer Center Assistant Professor of Medicine Weill Cornell Medical College New York, New York
The development of this pamphlet was supported by unrestricted educational grants from Alkermes; Amgen; Bristol Myers Squibb; and Novartis Pharmaceutical Corporation.
ABOUT AIM AT MELANOMA By directing and funding paradigm-shifting research initiatives; educating patients, healthcare professionals, and the public; and advocating for survivors and their families, AIM at Melanoma’s goal is to end this disease in our lifetime while improving the lives of those it affects. Founded in 2004, AIM at Melanoma is a global foundation dedicated to finding more effective treatments and, ultimately, the cure for melanoma.
AIM at Melanoma is dedicated to: Innovation in Melanoma Research We believe that the cure for melanoma will be found more quickly by bringing together leading global researchers and funding their collaborative research. Our paradigm-shifting global research initiatives, including the International Melanoma Tissue Bank Consortium, are poised to reshape the future of melanoma.
Legislation, Policy & Advocacy We are the respected voice of melanoma across the nation. When drugs are approved, legislation is drafted, and research is assessed, AIM is at the table, speaking loudly and clearly on behalf of patients and their families. We are trusted advisors for government agencies, medical boards, and pharmaceutical companies on critical topics that affect melanoma patients.
Information & Support Both in the United States and on a global level we provide comprehensive, easy-to-access melanoma resources for patients and health care professionals. AIM’s patient, family, and caregiver support offerings—such as our Ask an Expert service, which allows patients to contact a melanoma physician assistant with their questions, and our Peer Connect program, which matches newly diagnosed patients with melanoma veterans—serve as models for other cancer foundations.
Stage IV Melanoma Treatment Options • Making the Decision That’s Right for You Copyright © 2022 AIM at Melanoma Foundation and Terranova Medica, LLC. All Rights Reserved. Document Released January 26, 2022.
54
